Status: Recruiting
A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
This is a first-in-human, multicenter, open-label, phase 1 study to evaluate the safety, PK, PD and preliminary efficacy of STX-0712 in patients with advanced CMML and AML for whom there are no further treatment options known to confer clinical benefit.
Participants needed: 105
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Solu Therapeutics, IncUpdated: Feb 9, 2026Locations: 7
Eligibility criteria
Refractory/resistant CMML, defined as: Diagnosis of CMML 1 or 2; and has not res... [+7]
Has any of the following disease-specific conditions: For CMML: Myelodysplastic... [+15]